share_log

Market-Moving News for September 19th

Market-Moving News for September 19th

9月19日市場動態新聞
Benzinga ·  09/19 08:06

GLMD: 60% | Galmed Pharmaceuticals Plans To Broaden Its Drug Development Activities, Consisting Of Two Additional Programs Over The Next Two Years

GLMD:60% | Galmed Pharmaceuticals計劃擴大其藥物開發活動,包括未來兩年內增加兩個項目

EWTX: 42% | Edgewise Therapeutics Announced Top-line Data Of EDG-7500 From The Phase 1 Trial In Healthy Subjects And The Single-dose Arm Of Phase 2 CIRRUS-HCMtrial In Patients With Obstructive Obstructive Hypertrophic Cardiomyopathy

EWTX:42% | Edgewise Therapeutics公佈了針對健康受試者的1期試驗和針對阻塞性梗阻性肥厚型心肌病患者的2期Cirrus-HCM試驗的單劑量組的 EDG-7500 主要數據

XCUR: 271% | Exicure shares are trading higher after the company announced it received an extension from the Nasdaq Hearings Panel.

XCUR:271% | Exicure宣佈獲得納斯達克聽證會小組的延期後,該公司股價走高。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論